VLP were propagated using human embryonic kidney, 293T cells (ATCC). Cells were maintained in Dulbecco’s Modified Eagle medium with 10% Fetal Bovine Serum. VLP-containing HXB2 envelope was produced by transient transfection of HEK 293T cells with pGag-EGFP and pHXB2 env using Lipofectamine 2000 transfection reagent (Life Technologies). Also, 107 cells in T175 flasks were transfected with 30 µg HXB2 envelope, 60 µg pGag-EGFP, and 360 µL Lipofectamine 2000 transfection reagent in serum/antibiotic-free medium. After 3–4 h of incubation at 37°C, the culture medium was replaced with DMEM + 10% FBS. VLP-containing supernatant was collected 72 h after transfection and clarified by centrifugation at 2,000 × g for 10 min. Clarified supernatant was further purified of cellular debris by 0.45 µm filtration. Purification of assembled VLP was completed by ultracentrifugation through a 20% sucrose pad at 122,000 × g for 2 h at 4°C. The VLP pellet was resuspended in filtered PBS.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.